Sepsis and acute renal failure

Intensive Care Medicine: Annual Update 2006

Volumn , Issue , 2007, Pages 673-679

  Schrier, R W ^a   Zolty, E ^a   Wang, W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892226008     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-35096-9_62     Document Type: Chapter

References (27)

1. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel P (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. J Am SocNeprhol 273:117-123
2. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P (1996) Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant 11:293-299
3. Hohlfeld T, Klemm P, Thiemermann C, Warner TD, Schror Vane JR (1995) The contribution of tumor necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin. Br J Pharmacol 116:3309-3315
4. Knotek M, Rogachev B, Wang W, et al (2001) Endotoxemic renal failure in mice: role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 59:2243-2249
5. Wang W, Falk SA, Jittikanont S, Gengaro PE, Edelstein CL, Schrier RW (2002) Protective effect of renal denervation on normotensive endotoxemia-induced acute renal failure in mice. Am J Physiol Renal Physiol 283:F583-587
6. Schwartz D, Mendonca M, Schwartz I, et al (1997) Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 100:439-448
7. Wang W, Mitra A, Pool BD, Falk SA, Schrier RW (2004) Endothelial nitric oxide synthase (eNOS) deficient mice exhibit increased susceptibility to endotoxin-induced acute renal failure (acute renal failure). Am J Physiol Renal Physiol 287: F1044-F1048
8. Knotek M, Esson M, Gengaro P, Edelstein C, Schrier RW (2000) Desensitization of soluble guanylate cyclase in renal cortex during endotoxemia in mice. J Am Soc Nephrol 11:2133-2137
9. Kikeri D, Pennell JP, Hwang KH, et al (1986) Endotoxemic acute renal failure in awake rats. Am J Physiol 250:F1098-1106
10. Sanz E, Lopez Novoa JM, Linares M, Digiuni E, Caramelo CA (1990) Intravascular and interstitial fluid dynamics in rats treated with minoxidil. J Cardiovasc Pharmacol 15:485-492
11. Schrier RW, Abraham E (1995) Aggressive volume expansion and pseudo-ARDS. Hosp Pract 30:19-23
12. Esson ML, Schrier RW (2002) Diagnosis and treatment of acute tubular necrosis. Ann Intern Med 137:744-752
13. Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 345: 588-595
14. Rivers E, Nguyen B, Havstad S, et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368-1377
15. Wang W, Zolty E, Mitra A, Falk S, Schrier RW (2005) Pentoxifylline protects mice against endotoxemic acute renal failure. American Society of Nephrology, Philadelphia (abst)
16. Cunningham P, Hristem M, Park P, Wang J, Newell K, Quigg R (2002) Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 168:5817-5823
17. Kon V, Badr KF (1991) Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int 40:1-12
18. th edn. Lippincott Williams and Wil-kins, Philadelphia, pp 1041-1070
19. Wang W Jittikanont S, Falk SA, et al (2003) Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure. Am J Physiol Renal Physiol 284:F532-F537
20. Alp N, Mussa S, Khoo J, et al (2003) Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest 112:725-735
21. Geraci M, Gao B, Shepher D, et al (1999) Pulmonary prostacyclin synthase overexpression in trnasgenic mice protects against development of hypoxic pulmonary hypertension. J Clin Invest 103:1509-1515
22. Mitra A, Bansal S, Wang W, Falk S, Zolty E, Schrier RW (2005) Erythropoeitin provides functional protection against endotoxemic acute renal failure in mice. American Society of Nephrology, Philadelphia (abst)
23. Van den Berghe G, Wouters P, Weekers F, et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:2359-2367
24. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G (2004) Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metabl 89:219-226
25. Langouche L, Vanhorebeek I, Vlasselaers D, et al (2005) Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115: 2277-2286
26. Hansen T, Thiel S, Wouters P, Christiansen J, Van den Berghe G (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88:1082-1088
27. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G (2005) Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365:53-59